APA (7th ed.) Citation

MA, P., PD, Z., SK, P., A, M., M, F., M, G., . . . KA, M. (2026). CD8 PET imaging with [89Zr]Zr-berdoxam-crefmirlimab in patients with solid tumors: The Phase II iCorrelate study. Journal for immunotherapy of cancer, 14(3), . https://doi.org/10.1136/jitc-2025-012208

Chicago Style (17th ed.) Citation

MA, Postow, et al. "CD8 PET Imaging with [89Zr]Zr-berdoxam-crefmirlimab in Patients with Solid Tumors: The Phase II ICorrelate Study." Journal for Immunotherapy of Cancer 14, no. 3 (2026). https://doi.org/10.1136/jitc-2025-012208.

MLA (9th ed.) Citation

MA, Postow, et al. "CD8 PET Imaging with [89Zr]Zr-berdoxam-crefmirlimab in Patients with Solid Tumors: The Phase II ICorrelate Study." Journal for Immunotherapy of Cancer, vol. 14, no. 3, 2026, https://doi.org/10.1136/jitc-2025-012208.